NO20065657L - Filmformet ostriol-inneholdende medikament for oral administrasjon - Google Patents

Filmformet ostriol-inneholdende medikament for oral administrasjon

Info

Publication number
NO20065657L
NO20065657L NO20065657A NO20065657A NO20065657L NO 20065657 L NO20065657 L NO 20065657L NO 20065657 A NO20065657 A NO 20065657A NO 20065657 A NO20065657 A NO 20065657A NO 20065657 L NO20065657 L NO 20065657L
Authority
NO
Norway
Prior art keywords
film
shaped
ostriol
oral administration
containing drug
Prior art date
Application number
NO20065657A
Other languages
English (en)
Inventor
Walter Elger
Joachim Moormann
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20065657L publication Critical patent/NO20065657L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår filmformede medikamenter som kan bli administrert oralt, særlig bukkalt og som er beregnet for behandling av klimakteriske plager, idet nevnte medikamenter inneholder østriol og/eller minst en farmakologisk akseptabel ester av østriol, enten alene eller i kombinasjon med et gestagen.
NO20065657A 2004-05-14 2006-12-07 Filmformet ostriol-inneholdende medikament for oral administrasjon NO20065657L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004023984A DE102004023984A1 (de) 2004-05-14 2004-05-14 Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
PCT/EP2005/004894 WO2005110358A2 (de) 2004-05-14 2005-05-06 Filmförmiges, oral zu verabreichendes arzneimittel, enthaltend estriol

Publications (1)

Publication Number Publication Date
NO20065657L true NO20065657L (no) 2006-12-07

Family

ID=34977101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065657A NO20065657L (no) 2004-05-14 2006-12-07 Filmformet ostriol-inneholdende medikament for oral administrasjon

Country Status (16)

Country Link
US (1) US20070243217A1 (no)
EP (1) EP1761242A2 (no)
JP (1) JP2007537178A (no)
KR (1) KR20070040753A (no)
CN (1) CN1997349A (no)
AR (1) AR048958A1 (no)
AU (1) AU2005244409A1 (no)
BR (1) BRPI0510855A (no)
CA (1) CA2566325A1 (no)
DE (1) DE102004023984A1 (no)
IL (1) IL179014A0 (no)
MX (1) MXPA06012890A (no)
NO (1) NO20065657L (no)
RU (1) RU2006140649A (no)
TW (1) TW200536547A (no)
WO (1) WO2005110358A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110052699A1 (en) * 2008-02-13 2011-03-03 Adrian Funke Drug delivery system with stabilising effect
NZ586666A (en) * 2008-02-13 2012-04-27 Bayer Schering Pharma Ag Estradiol-containing drug delivery system
EP2293779A1 (en) * 2008-04-24 2011-03-16 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
WO2010033832A2 (en) * 2008-09-19 2010-03-25 Evestra, Inc. Estriol formulations
DE102009007771B4 (de) * 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
KR102044515B1 (ko) * 2019-08-20 2019-11-14 이영환 구강점막 부착력이 우수한 서방형 구강붕해용 필름 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
WO1993018774A1 (de) * 1992-03-21 1993-09-30 Entec Gesellschaft Für Endokrinologische Technologie M.B.H. Verwendung von östriol zur behandlung von klimakterischer osteoporose
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
DE19932603A1 (de) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
DE60113809T2 (de) * 2000-01-18 2006-06-22 Schering Ag Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie

Also Published As

Publication number Publication date
DE102004023984A1 (de) 2005-12-08
EP1761242A2 (de) 2007-03-14
IL179014A0 (en) 2007-03-08
TW200536547A (en) 2005-11-16
AU2005244409A1 (en) 2005-11-24
WO2005110358A2 (de) 2005-11-24
AR048958A1 (es) 2006-06-14
CA2566325A1 (en) 2005-11-24
CN1997349A (zh) 2007-07-11
WO2005110358A3 (de) 2007-03-15
US20070243217A1 (en) 2007-10-18
MXPA06012890A (es) 2007-07-19
JP2007537178A (ja) 2007-12-20
RU2006140649A (ru) 2008-05-27
KR20070040753A (ko) 2007-04-17
BRPI0510855A (pt) 2007-12-26

Similar Documents

Publication Publication Date Title
EP2444072A3 (en) Non-mucoadhesive film dosage forms
PE20040134A1 (es) Forma de dosificacion de una vez al dia de pramipexol
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
NO20065657L (no) Filmformet ostriol-inneholdende medikament for oral administrasjon
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
WO2004105694A3 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
CR7654A (es) Una combinacion de azelatina y esteroides
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
EA201100313A1 (ru) Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
WO2002043765A3 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
JP2006508953A5 (no)
EP2216024A3 (en) Use of Ranolazine for the treatment of cardiovascular diseases
JP2009517411A5 (no)
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
NO20073403L (no) Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1
WO2009026473A3 (en) Stabilized therapeutic compositions and formulations
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
NO20044496L (no) Torr pulver innhaleringssammensetning
NO20080244L (no) Doseringsstyring for prasugrel
NO20091644L (no) Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist
WO2007086079A3 (en) Sustained release dosage form of phenothiazine derivatives containing channelizer
EP1778209B8 (en) Methods and compositions for oral delivery of fts
JP2011500589A5 (no)
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases